Last 7 days
0.2%
Last 30 days
1.2%
Last 90 days
54.1%
Trailing 12 Months
14.7%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2022-02-17 | Rolle Myron L | sold (taxes) | -36,447 | 325 | -112 | - |
2022-02-17 | SUTTER MARTIN P | sold | -1,258,850 | 314 | -4,000 | - |
2022-02-16 | SUTTER MARTIN P | sold | -617,322 | 308 | -2,000 | - |
2022-02-16 | Weber David M | sold | -2,437,500 | 325 | -7,500 | chief operating officer |
2022-02-15 | SUTTER MARTIN P | sold | -607,301 | 303 | -2,000 | - |
2022-02-09 | Weber David M | acquired | 67,063 | 21.55 | 3,112 | chief operating officer |
2022-02-09 | Weber David M | sold | -965,311 | 310 | -3,112 | chief operating officer |
2022-02-08 | Weber David M | acquired | 159,750 | 21.55 | 7,413 | chief operating officer |
2022-02-08 | Weber David M | sold | -2,245,420 | 302 | -7,413 | chief operating officer |
2022-02-07 | Weber David M | acquired | 6,465 | 21.55 | 300 | chief operating officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | sold off | -100 | -1,501,000 | - | -% |
2023-08-11 | HUNTINGTON NATIONAL BANK | unchanged | - | - | 381 | -% |
2023-03-17 | American Portfolios Advisors | reduced | -10.72 | -21,822 | 169,751 | 0.01% |
2023-02-13 | SEEYOND | sold off | -100 | -954,000 | - | -% |
2023-02-13 | HERITAGE WEALTH MANAGEMENT, LLC | sold off | -100 | -10,000 | - | -% |
2023-02-06 | Brinker Capital Investments, LLC | sold off | -100 | -2,066,000 | - | -% |
2023-01-24 | Autus Asset Management, LLC | sold off | -100 | -3,702,000 | - | -% |
2022-11-21 | 17 CAPITAL PARTNERS, LLC | unchanged | - | -2,000 | 281,000 | 0.38% |
2022-11-21 | FourThought Financial, LLC | reduced | -6.88 | -6,000 | 73,000 | 0.01% |
2022-11-15 | Covington Capital Management | new | - | 1,000 | 1,000 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jan 06, 2023 | baillie gifford & co | 0.01% | 2,991 | SC 13G/A | |
Dec 29, 2022 | millennium management llc | 0.0% | 0 | SC 13G | |
Feb 09, 2022 | vanguard group inc | 10.64% | 4,842,984 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 5.41% | 2,461,221 | SC 13G | |
Jan 18, 2022 | baillie gifford & co | 8.44% | 3,839,980 | SC 13G/A | |
Jan 10, 2022 | blackrock inc. | 10.1% | 4,592,566 | SC 13G/A | |
Feb 16, 2021 | sands capital management, llc | 3.27% | 1,479,909 | SC 13G | |
Feb 10, 2021 | renaissance technologies llc | 4.41% | 1,993,800 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 10.63% | 4,801,759 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 9.1% | 4,127,359 | SC 13G/A |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 109.7B | 19.5B | 4.61% | 32.58% | 40.5 | 5.64 | 10.36% | 30.30% |
ISRG | 102.6B | 6.7B | 1.85% | 46.31% | 71.98 | 15.39 | 11.75% | -0.66% |
BSX | 78.2B | 13.4B | 7.30% | 33.81% | 85.79 | 5.84 | 8.69% | 3.17% |
BDX | 71.3B | 19.0B | -3.08% | 10.26% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 43.7B | 5.7B | -5.74% | -17.48% | 31.48 | 7.73 | 5.64% | -4.53% |
MID-CAP | ||||||||
PEN | 10.1B | 937.8M | 5.52% | 36.72% | 345.25 | 10.72 | 16.30% | 250.21% |
SWAV | 7.5B | 616.6M | -7.14% | -29.65% | 30.68 | 12.13 | 69.52% | 343.68% |
GMED | 5.3B | 1.1B | -4.57% | -12.56% | 25.23 | 4.84 | 12.63% | 50.85% |
IRTC | 2.7B | 452.1M | -16.85% | -42.51% | -27.51 | 6.04 | 24.99% | 24.09% |
TNDM | 1.5B | 790.3M | -18.06% | -57.30% | -6.6 | 1.87 | 3.21% | -1604.53% |
SMALL-CAP | ||||||||
ATEC | 1.6B | 421.8M | -8.54% | 49.60% | -9.62 | 3.81 | 44.49% | -2.43% |
AVNS | 952.1M | 780.7M | -7.00% | -11.88% | -26.45 | 1.22 | 4.68% | -510.17% |
CSII | 839.3M | 239.8M | 0.70% | 0.15% | -22.16 | 3.5 | -4.74% | -31.15% |
SILK | 620.2M | 162.9M | -26.12% | -63.06% | -11.73 | 3.81 | 42.67% | 12.82% |
39.5%
23.2%
14.7%
32.7%
80%
58.1%
31.5%
Y-axis is the maximum loss one would have experienced if Abiomed was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 |
Revenue | 1.7% | 1,074 | 1,056 | 1,032 | 1,003 | 974 | 935 | 848 | 813 | 803 | 798 | 841 | 841 | 820 | 797 | 769 | 737 | 690 | 641 | 594 | 544 | 505 |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99.00 | 88.00 | 82.00 |
Costs and Expenses | 2.5% | 820 | 800 | 891 | 865 | 828 | 789 | 618 | 588 | 579 | 576 | 592 | 585 | 572 | 558 | 545 | 530 | 501 | 470 | 437 | 405 | 385 |
S&GA Expenses | 3.2% | 452 | 438 | 423 | 414 | 393 | 369 | 334 | 318 | 317 | 324 | 342 | 339 | 334 | 326 | 322 | 316 | 302 | 283 | 263 | 247 | 235 |
R&D Expenses | 0.6% | 167 | 166 | 163 | 152 | 144 | 133 | 122 | 115 | 108 | 101 | 99.00 | 99.00 | 97.00 | 96.00 | 94.00 | 89.00 | 83.00 | 80.00 | 75.00 | 70.00 | 69.00 |
EBITDA | 23.9% | 369 | 298 | 219 | 217 | 239 | 243 | 313 | 278 | 293 | 237 | 278 | 335 | 301 | - | - | - | - | - | - | - | - |
EBITDA Margin | 21.9% | 0.34* | 0.28* | 0.21* | 0.22* | 0.25* | 0.26* | 0.37* | 0.34* | 0.37* | 0.30* | 0.33* | 0.40* | 0.37* | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 1.00 |
Earnings Before Taxes | 26.5% | 341 | 270 | 191 | 189 | 212 | 218 | 288 | 254 | 270 | 215 | 257 | 316 | 284 | 318 | 263 | 213 | 194 | 175 | 160 | 141 | 121 |
EBT Margin | 24.4% | 0.32* | 0.26* | 0.18* | 0.19* | 0.22* | 0.23* | 0.34* | 0.31* | 0.34* | 0.27* | 0.31* | 0.38* | 0.35* | - | - | - | - | - | - | - | - |
Net Income | 22.6% | 267 | 218 | 137 | 133 | 149 | 154 | 226 | 200 | 208 | 159 | 203 | 245 | 221 | 258 | 259 | 222 | 190 | 165 | 112 | 90.00 | 92.00 |
Net Income Margin | 20.6% | 0.25* | 0.21* | 0.13* | 0.13* | 0.15* | 0.17* | 0.27* | 0.25* | 0.26* | 0.20* | 0.24* | 0.29* | 0.27* | - | - | - | - | - | - | - | - |
Free Cashflow | -17.3% | 217 | 263 | 250 | 246 | 233 | 248 | 221 | 237 | 246 | 240 | 271 | 257 | 243 | - | - | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 |
Assets | -0.4% | 1,697 | 1,704 | 1,673 | 1,593 | 1,530 | 1,458 | 1,494 | 1,428 | 1,328 | 1,250 | 1,216 | 1,197 | 1,124 | 1,125 | 1,054 | 957 | 887 | 812 | 786 | 720 | 695 |
Current Assets | 0.2% | 1,063 | 1,060 | 976 | 885 | 871 | 730 | 788 | 694 | 717 | 620 | 636 | 637 | 647 | 677 | 677 | 629 | 562 | 497 | 494 | 422 | 370 |
Cash Equivalents | 1.0% | 182 | 180 | 133 | 144 | 242 | 175 | 233 | 181 | 202 | 215 | 192 | 118 | 150 | 101 | 121 | 84.00 | 76.00 | 61.00 | 43.00 | 51.00 | 45.00 |
Inventory | 7.2% | 102 | 95.00 | 94.00 | 90.00 | 86.00 | 84.00 | 81.00 | 82.00 | 83.00 | 89.00 | 90.00 | 91.00 | 90.00 | 88.00 | 81.00 | 72.00 | 64.00 | 56.00 | 50.00 | 47.00 | 41.00 |
Net PPE | -1.7% | 195 | 198 | 202 | 197 | 197 | 198 | 197 | 179 | 176 | 170 | 165 | 162 | 158 | 152 | 145 | 138 | 134 | 127 | 117 | 108 | 98.00 |
Goodwill | -2.5% | 73.00 | 75.00 | 77.00 | 77.00 | 78.00 | 79.00 | 79.00 | 80.00 | 78.00 | 77.00 | 32.00 | 33.00 | 32.00 | 33.00 | 33.00 | 33.00 | 34.00 | 34.00 | 36.00 | 35.00 | 34.00 |
Liabilities | -6.4% | 157 | 167 | 170 | 160 | 145 | 151 | 165 | 167 | 146 | 148 | 151 | 150 | 133 | 122 | 117 | 106 | 94.00 | 89.00 | 97.00 | 87.00 | 90.00 |
Current Liabilities | -4.8% | 134 | 141 | 138 | 127 | 114 | 113 | 129 | 120 | 105 | 110 | 132 | 126 | 112 | 100 | 106 | 93.00 | 82.00 | 77.00 | 85.00 | 75.00 | 63.00 |
Shareholder's Equity | 0.2% | 1,540 | 1,536 | 1,503 | 1,433 | 1,385 | 1,308 | 1,330 | 1,261 | 1,182 | 1,102 | 1,065 | 1,047 | 991 | 1,003 | 937 | 852 | 793 | 723 | 690 | 632 | 605 |
Retained Earnings | 10.4% | 1,125 | 1,019 | 965 | 904 | 858 | 801 | 828 | 771 | 709 | 647 | 602 | 571 | 501 | 488 | 399 | 326 | 281 | 231 | 140 | 104 | 90.00 |
Additional Paid-In Capital | 2.2% | 905 | 885 | 870 | 853 | 840 | 815 | 801 | 782 | 768 | 749 | 739 | 733 | 722 | 705 | 691 | 676 | 660 | 638 | 620 | 606 | 592 |
Shares Outstanding | -0.9% | 45.00 | 46.00 | 46.00 | 46.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 44.00 | 44.00 | 44.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 |
Cashflow From Operations | -15.8% | 251 | 298 | 285 | 293 | 282 | 298 | 275 | 275 | 285 | 282 | 315 | 299 | 284 | 270 | 252 | 238 | 220 | 203 | 193 | 173 | 151 |
Share Based Compensation | 0.5% | 54.00 | 53.00 | 53.00 | 54.00 | 55.00 | 50.00 | 47.00 | 36.00 | 34.00 | 36.00 | 40.00 | 48.00 | 53.00 | 55.00 | 54.00 | 55.00 | 51.00 | 44.00 | 40.00 | 38.00 | 33.00 |
Cashflow From Investing | 38.2% | -162 | -263 | -380 | -324 | -250 | -346 | -223 | -177 | -168 | -65.76 | -125 | -171 | -139 | -197 | -116 | -149 | -135 | -128 | -180 | -181 | -158 |
Cashflow From Financing | -626.0% | -135 | -18.67 | -2.20 | -1.58 | 6.00 | 5.00 | -8.07 | -35.20 | -61.42 | -98.60 | -117 | -92.93 | -69.10 | -33.25 | -55.77 | -56.24 | -53.52 | -56.50 | -9.14 | -1.29 | 0.00 |
Buy Backs | 772.2% | 253 | 29.00 | - | - | - | - | 11.00 | 36.00 | 61.00 | 96.00 | 85.00 | 120 | 139 | - | - | - | - | - | - | - | - |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Statement [Abstract] | ||||
Revenue | $ 265,921 | $ 248,142 | $ 543,070 | $ 500,727 |
Costs and expenses: | ||||
Cost of revenue | 48,880 | 43,886 | 101,506 | 89,074 |
Research and development | 42,089 | 41,041 | 82,566 | 78,749 |
Selling, general and administrative | 116,958 | 102,779 | 234,954 | 206,263 |
Acquired in-process research and development | 0 | 0 | 0 | 115,490 |
Costs and Expenses, Total | 207,927 | 187,706 | 419,026 | 489,576 |
Other (loss) income: | ||||
Income from operations | 57,994 | 60,436 | 124,044 | 11,151 |
Interest and other income, net | 80,709 | 6,835 | 84,481 | 46,770 |
Income before income taxes | 138,703 | 67,271 | 208,525 | 57,921 |
Income tax provision | 32,570 | 10,318 | 47,838 | 27,493 |
Net income | $ 106,133 | $ 56,953 | $ 160,687 | $ 30,428 |
Net income per share - basic | $ 2.34 | $ 1.25 | $ 3.53 | $ 0.67 |
Weighted average shares outstanding - basic | 45,372 | 45,437 | 45,475 | 45,374 |
Net income per share - diluted | $ 2.32 | $ 1.24 | $ 3.51 | $ 0.66 |
Weighted average shares outstanding - diluted | 45,711 | 45,893 | 45,812 | 45,857 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Sep. 30, 2022 | Mar. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 182,335 | $ 132,818 |
Short-term marketable securities | 638,037 | 625,789 |
Accounts receivable, net | 94,475 | 90,608 |
Inventories, net | 102,237 | 93,981 |
Prepaid expenses and other current assets | 45,714 | 33,277 |
Total current assets | 1,062,798 | 976,473 |
Long-term marketable securities | 116,871 | 220,089 |
Property and equipment, net | 195,157 | 202,490 |
Goodwill | 72,960 | 76,786 |
Other intangibles, net | 36,833 | 39,518 |
Deferred tax assets | 18,881 | 10,552 |
Other assets | 193,044 | 147,485 |
Total assets | 1,696,544 | 1,673,393 |
Current liabilities: | ||
Accounts payable | 35,070 | 35,346 |
Accrued expenses | 69,434 | 72,629 |
Deferred revenue | 25,962 | 26,362 |
Other current liabilities | 3,594 | 4,120 |
Total current liabilities | 134,060 | 138,457 |
Other long-term liabilities | 7,013 | 9,319 |
Contingent consideration | 14,995 | 21,510 |
Deferred tax liabilities | 689 | 781 |
Total liabilities | 156,757 | 170,067 |
Commitments and contingencies (Note 16) | ||
Stockholders' equity: | ||
Class B Preferred Stock, $.01 par value Authorized - 1,000,000 shares; Issued and outstanding - none | ||
Common stock, $.01 par value 100,000 shares authorized; 48,418 and 48,258 shares issued as of September 31, 2022 and March 31, 2022, respectively 45,172 and 45,545 shares outstanding as of September 30, 2022 and March 31, 2022, respectively | 452 | 455 |
Additional paid in capital | 904,755 | 870,074 |
Retained earnings | 1,125,199 | 964,512 |
Treasury stock at cost - 3,246 and 2,713 shares as of September 31, 2022 and March 31, 2022, respectively | (443,974) | (304,555) |
Accumulated other comprehensive loss | (46,645) | (27,160) |
Total stockholders' equity | 1,539,787 | 1,503,326 |
Total liabilities and stockholders' equity | $ 1,696,544 | $ 1,673,393 |